Marker Therapeutics, Inc. (MRKR)

1.45 -0.05 (-3.33%) USD  |  NASDAQ  |  Feb 20, 16:00
1.43 -0.02 (-1.38%) After-Hours: 07:22
More

Marker Therapeutics EBITDA (% of Quarterly Revenues)

EBITDA (% of Quarterly Revenues) Chart

View EBITDA (% of Quarterly Revenues) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (% of Quarterly Revenues) Range, Past 5 Years

View EBITDA (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (% of Quarterly Revenues) Benchmarks

View EBITDA (% of Quarterly Revenues) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade